TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Reviva Bio AB
Closing information (x1000 SEK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
18,405
|
11,776
|
10,417 |
Financial expenses |
6
|
0
|
1 |
Earnings before taxes |
1,450
|
1,184
|
1,795 |
EBITDA |
1,551
|
1,267
|
1,868 |
Total assets |
13,039
|
6,822
|
5,402 |
Current assets |
12,708
|
6,547
|
5,150 |
Current liabilities |
6,486
|
1,445
|
1,005 |
Equity capital |
5,812
|
4,676
|
3,747 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
11
|
8
![]() |
8 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
44.6%
|
68.5%
|
69.4% |
Turnover per employee |
1,673
|
1,472
|
1,302 |
Profit as a percentage of turnover |
7.9%
|
10.1%
|
17.2% |
Return on assets (ROA) |
11.2%
|
17.4%
|
33.2% |
Current ratio |
195.9%
|
453.1%
|
512.4% |
Return on equity (ROE) |
24.9%
|
25.3%
|
47.9% |
Change turnover |
6,629
|
1,359
|
2,786 |
Change turnover % |
56%
|
13%
|
37% |
Chg. No. of employees |
3
|
0
|
1 |
Chg. No. of employees % |
38%
|
0%
|
14% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.